Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 0.00 | 0.02 | 0.01 | 0.17 | 0.83 | 1.21 | 0.13 | 1.12 | 5.97 | 0.83 | 2.69 | 0.00 |
| Operating costs | 1.02 | 2.45 | 1.81 | 1.89 | 1.97 | 2.94 | 2.82 | 6.00 | 10.55 | 4.50 | 3.77 | 0.88 |
| EBITDA | -1.02 | -2.43 | -1.80 | -1.72 | -1.14 | -1.73 | -2.69 | -4.88 | -4.58 | -3.67 | -1.08 | -0.88 |
| EBITDA margin % | -12,150.00% | -18,000.00% | -1,011.76% | -137.35% | -142.98% | -2,069.23% | -435.71% | -76.72% | -442.17% | -40.15% | ||
| Depreciation & amortisation | 0.01 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 | 0.05 | 0.06 |
| Finance costs | 0.00 | 0.02 | 0.29 | 0.01 | 0.01 | 0.07 | 2.05 | 1.11 | 1.02 | 0.57 | 0.60 | 0.57 |
| Non-operating income | -0.26 | 0.76 | 0.03 | 0.00 | 0.01 | 0.00 | 1.01 | 0.35 | 3.32 | 0.06 | 0.04 | 4.25 |
| Pre-tax profit | -1.29 | -1.73 | -2.11 | -1.78 | -1.19 | -1.85 | -3.78 | -5.69 | -2.34 | -4.23 | -1.69 | 2.74 |
| Effective tax rate % | -60.47% | -33.53% | 6.16% | -8.43% | -15.13% | -13.51% | -19.05% | -23.37% | -29.06% | -26.71% | -22.49% | 22.26% |
| Profit after tax | -0.50 | -1.15 | -2.24 | -1.62 | -1.01 | -1.59 | -3.06 | -4.36 | -1.65 | -3.11 | -1.31 | 2.13 |
| Earnings per share (Rs) | -0.23 | -0.54 | -0.64 | -0.46 | -0.29 | -0.45 | -0.87 | -1.24 | -0.47 | -0.88 | -0.37 | 0.60 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 1.68 | 1.20 | 0.45 | 0.56 | 0.00 | 8.55 | 3.94 | 0.00 | 0.03 | 2.34 | 10.60 | 9.49 |
| Operating costs | 2.03 | 1.54 | 0.84 | 0.67 | 0.34 | 8.45 | 3.81 | 9.89 | 6.41 | 9.60 | 24.80 | 19.70 |
| EBITDA | -0.35 | -0.34 | -0.39 | -0.11 | -0.34 | 0.10 | 0.13 | -9.89 | -6.38 | -7.26 | -14.20 | -10.21 |
| EBITDA margin % | -20.83% | -28.33% | -86.67% | -19.64% | 1.17% | 3.30% | -21,266.67% | -310.26% | -133.96% | -107.59% | ||
| Depreciation & amortisation | 0.10 | 0.06 | 0.00 | 0.05 | 0.04 | 0.04 | 0.01 | 0.02 | 0.18 | 0.20 | 0.21 | 0.22 |
| Finance costs | 0.03 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.33 | 2.15 | 3.31 | 2.76 |
| Non-operating income | 0.05 | 0.53 | 0.02 | 0.01 | 0.00 | 0.03 | 0.02 | 0.00 | 0.80 | 1.02 | 3.77 | 7.67 |
| Pre-tax profit | -0.43 | 0.09 | -0.37 | -0.15 | -0.38 | 0.09 | 0.14 | -9.91 | -6.09 | -8.59 | -13.95 | -5.52 |
| Effective tax rate % | -6.98% | -33.33% | 5.41% | 20.00% | -107.89% | 0.00% | 0.00% | -23.71% | -18.72% | -15.25% | -25.23% | |
| Profit after tax | -0.40 | 0.11 | -0.39 | -0.18 | 0.03 | 0.09 | 0.15 | -7.56 | -4.95 | -7.28 | -10.44 | -3.94 |
| Earnings per share (Rs) | -1.17 | 0.32 | -1.15 | -0.53 | 0.03 | 0.09 | 0.15 | -3.52 | -1.40 | -2.06 | -2.96 | -1.12 |
| Paid out as dividend % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Revenue CAGR | 20% | 4% | % | 188% | ||
| Profit CAGR | % | % | -41% | -6% | ||
| Share price CAGR | 23% | 16% | -9% | -50% | ||
| Average return on equity | -15% | -17% | -15% | -23% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net block (property, plant) | 0.46 | 0.44 | 0.00 | 0.00 | 0.08 | 0.08 | 0.04 | 0.03 | 0.11 | 16.55 | 24.18 | 8.05 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.45 | 0.45 | 0.45 | 0.45 | 2.00 | 2.30 | 3.51 | 5.47 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.27 | 52.60 | 52.61 | 52.54 |
| Current & other assets | 2.06 | 1.86 | 2.02 | 1.30 | 8.14 | 7.93 | 8.63 | 10.63 | 19.18 | 13.54 | 34.42 | 17.90 |
| Total assets | 2.52 | 2.30 | 2.02 | 1.30 | 8.67 | 8.46 | 9.12 | 11.11 | 24.56 | 84.99 | 114.72 | 83.96 |
| Share capital | 3.36 | 3.36 | 3.36 | 3.36 | 10.27 | 10.27 | 10.27 | 10.27 | 21.44 | 35.27 | 35.27 | 35.27 |
| Reserves & surplus | -1.65 | -2.05 | -1.94 | -2.32 | -1.87 | -1.84 | -1.74 | -1.60 | 0.98 | 35.79 | 28.52 | 18.11 |
| Total debt | 0.30 | 0.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.93 | 35.74 | 20.63 |
| Other liabilities & provisions | 0.51 | 0.51 | 0.60 | 0.26 | 0.27 | 0.03 | 0.59 | 2.44 | 2.14 | 1.00 | 15.19 | 9.95 |
| Equity + liabilities | 2.52 | 2.30 | 2.02 | 1.30 | 8.67 | 8.46 | 9.12 | 11.11 | 24.56 | 84.99 | 114.72 | 83.96 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 0.21 | 0.02 | 0.33 | -0.21 | -0.10 | -0.75 | 0.41 | -0.26 | -4.02 | -3.44 | -7.72 | -3.53 |
| Investing cash flow | -0.01 | -0.08 | 0.33 | -0.09 | 0.00 | 0.66 | -0.23 | 0.47 | -4.95 | -72.51 | -18.90 | 24.53 |
| Free cash flow (after capex) | 0.20 | -0.06 | 0.70 | -0.21 | -0.12 | -0.79 | 0.41 | -0.26 | -5.69 | -19.81 | -16.76 | 13.57 |
| Financing cash flow | -0.13 | 0.05 | -0.22 | -0.07 | -0.03 | 0.00 | 0.00 | 0.00 | 21.31 | 65.66 | 24.64 | -21.36 |
| Net change in cash | 0.06 | -0.01 | 0.43 | -0.37 | -0.13 | -0.09 | 0.18 | 0.21 | 12.35 | -10.29 | -1.99 | -0.36 |
| Cash conversion (OCF / EBITDA) % | -233% | -6% | -97% | 49% | 91% | 221% | 410% | -200% | 41% | 54% | 106% | 25% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on capital employed % | -5.26% | -21.05% | -24.30% | -30.08% | -3.18% | -4.52% | 1.06% | 1.63% | -63.75% | -10.83% | -7.02% | -15.85% |
| Receivable days | 234.19 | 232.47 | 240.29 | 421.78 | 580.09 | 11.95 | 124.14 | 0.00 | 24.96 | 47.52 | ||
| Inventory days | 102.77 | 91.25 | 130.75 | 0.00 | 0.00 | 16.55 | 90.99 | 0.00 | 4,197.50 | 1,774.15 | 0.00 | |
| Payable days | 145.29 | 138.45 | 245.15 | 22.37 | 236.18 | 0.00 | 2,066.52 | |||||
| Cash cycle (days) | 191.67 | 185.27 | 125.89 | 421.78 | 580.09 | 6.14 | -21.05 | 4,197.50 | -267.41 | 47.52 | ||
| Working capital days | 181.45 | 147.74 | 161.21 | 227.11 | 2,652.77 | 2.99 | -17.60 | 14,600.00 | -471.07 | -342.27 |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter group % | 9.70% | 9.25% | 5.64% | 5.56% | 5.19% | 5.22% | 5.22% | 5.14% | 32.99% | 32.99% | 32.99% | 32.99% |
| Retail & others % | 90.31% | 90.75% | 94.36% | 94.44% | 94.81% | 94.79% | 94.78% | 94.87% | 67.00% | 67.01% | 67.00% | 67.02% |
| Shareholder count | 7,393 | 7,281 | 7,567 | 7,594 | 8,049 | 8,349 | 8,220 | 8,026 | 8,027 | 8,288 | 8,406 | 8,632 |
Fundamentals
Market value₹ 105 Cr.
Last price₹ 29.9
Book value / share₹ 15.1
Return on capital-15.8 %
Return on equity-23.1 %
Dividend yield0.00 %
Face value₹ 10.0
Revenue CAGR (TTM)188%
Profit CAGR (TTM)-6%
Standalone figures.
Valuation
Market capRs 106 Cr
Enterprise valueRs 127 Cr
Price to book1.99x
Price to sales10.03x
EV / sales11.97x
Earnings yield-3.71%
P/B, 3-year average2.74x
P/E, 5-year average86.00x
P/B, 5-year average2.36x
Profitability
Operating margin (excl. other income)-133.96%
Operating margin (incl. other income)-98.40%
EBITDA margin-23.96%
Pre-tax margin-52.08%
Net profit margin-37.17%
ROE-17.82%
ROCE-12.26%
ROA-10.51%
ROE, 3-year average-13.07%
ROCE, 3-year average-10.04%
ROA, 3-year average-8.95%
ROE, 5-year average-17.22%
ROCE, 5-year average-18.45%
ROA, 5-year average-13.55%
ROIC (approx.)-2.79%
Tax rate25.23%
Other income / net worth7.06%
Growth
Sales growth (latest year)352.99%
Sales CAGR, 5 years4.39%
Per share
EPS (TTM)Rs -1.12
EPS (latest year)Rs -2.96
EPS (latest quarter)Rs 0.60
EPS, 3-year averageRs -2.14
EPS, 5-year averageRs -1.96
Book value per shareRs 15.14
Sales per shareRs 3.01
Cash flow per shareRs -1.00
Efficiency
Asset turnover0.13x
Fixed asset turnover1.32x
Debtor days48 days
Debtors turnover7.68x
Leverage
Total debtRs 21 Cr
Cash and bankRs 0 Cr
Net debtRs 21 Cr
Debt to equity0.39x
Interest coverage-1.00x
Owners' fund to total sources63.58%
Debt to assets24.57%
Cash flow
Operating cash flow (latest year)Rs -4 Cr
Investing cash flow (latest year)Rs 25 Cr
Financing cash flow (latest year)Rs -21 Cr
Net change in cash (latest year)Rs -0 Cr
Statement figures
Net sales (TTM)Rs 11 Cr
Net sales (latest year)Rs 11 Cr
Operating profit excl. other income (latest year)Rs -14 Cr
Operating profit (latest quarter)Rs -1 Cr
Other income (TTM)Rs 8 Cr
EBITDA (TTM)Rs -3 Cr
PBDT (TTM)Rs -5 Cr
Profit before tax (TTM)Rs -6 Cr
Tax (latest year)Rs -4 Cr
Net profit (TTM)Rs -4 Cr
Net profit (latest year)Rs -10 Cr
Net profit (latest quarter)Rs 2 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 3 Cr
Cost of goods sold (latest year)Rs 12 Cr
Total expenditure (latest year)Rs 25 Cr
Total income (latest year)Rs 14 Cr
Share capitalRs 35 Cr
ReservesRs 18 Cr
Shareholders' fundsRs 53 Cr
Total assetsRs 84 Cr
Net blockRs 8 Cr
Capital work in progressRs 5 Cr
InvestmentsRs 53 Cr
ReceivablesRs 1 Cr
Other liabilitiesRs 10 Cr
Shares outstanding (crore)3.53
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 1.99 is at the 10th percentile (median 5.77).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 524572 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +1.2% | -2.8% | +4.0 pts |
| 1 month | -6.6% | -6.8% | +0.2 pts |
| 3 months | -22.6% | -7.6% | -15.0 pts |
| 3 years | -22.7% | +14.2% | -36.9 pts |
| 5 years | +108.2% | +27.9% | +80.3 pts |
Red flags
F-score 5 of 8| explain | Receivables outrunning sales Receivables grew 762% vs sales +353% in 2026 |
| explain | Share dilution Share count up 0% in a year, 64% in three |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹0 Cr -100.0% vs Jun 2025.
Net profit ₹2 Cr +148.9%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Pharmaids Pharmaceuticals Ltd?
Pharmaids Pharmaceuticals Ltd (524572) has a market capitalisation of Rs 105 Cr. at the 2026-10-01 close.
What were Pharmaids Pharmaceuticals Ltd's latest quarterly results?
In the Jun 2026 quarter, Pharmaids Pharmaceuticals Ltd sales was Rs 0 Cr (-100.0% vs Jun 2025) and net profit was Rs 2 Cr.